FDA OKs 1st targeted drug for common lung cancer mutation
FAIRLESS HILLS, PA. (AP) — U.S. regulators have approved the first medicine for patients with the most common type of lung cancer whose tumors have a genetic mutation long considered untreatable with drugs. The Food […]